Erik Holmer
Head of R&D
medicine
Dilafor AB
Sweden
Biography
Erik Holmer earned a PhD in Biochemistry in 1987. From 1973 to 1989, he held various positions in the R&D dept. of KabiVitrum (later Pharmacia Corp), primarily in managing research in the field of coagulation, thrombosis and hemostasis, heparin and development of new antithrombotic agents. Dr. Holmer is the co-inventor and project leader for the development of the Low-Molecular-Weight-Heparin Fragmin (1978-1989). From 1990 to 2004, he held the position of Director of R&D at Carmeda AB, a subsidiary of W.L. Gore & Associates, Inc., where he led the development of heparin-based blood compatible surface coatings for medical devices. Dr. Holmer is a Co-founder of Dilafor.
Research Interest
MEDICINE
